Stock FARN FARON PHARMACEUTICALS OY
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Faron Pharmaceuticals Oy

Equities

FARN

FI4000153309

Delayed London S.E.
Other stock markets
 07:13:52 2024-04-24 am EDT 		5-day change 1st Jan Change
127 GBX -0.38% Intraday chart for Faron Pharmaceuticals Oy +5.84% -58.36%
Apr. 16 Faron Pharmaceuticals Oy Confirms Plans for the Coming Months CI
Apr. 15 Faron Pharmaceuticals reappoints former finance chief on interim basis AN

Evolution of the average Target Price on Faron Pharmaceuticals Oy

Price target over the last 5 years

History of analyst recommendation changes

8ae1d52f9e54.S09_nrWzCOV0puFlrwYt2_43KBmS73tndxzzlI9YmqQ.JXY-1_r5a4ozwY0I5VFA7MZPRX7QiQE9H2TBxsoM7-84Fhmu9thOvwLh1Q~1f87e379c97eac4465b084c14cf5a355

Analyst Recommendations on Faron Pharmaceuticals Oy

Faron Pharmaceuticals Reports 100% Response Rate in Phase 1 Trial of Myeloid Leukemia Combo Drug MT
Faron Pharmaceuticals' Bexmarilimab shows 50% remission rate AN
Faron Halts Investigational COVID-19 Therapy Trial Due to Low Infection, Hospitalization Rates MT
Faron Closes HIBISCUS Trial Due to Low COVID-19 Infection and Hospitalization Rates in the US and Reverts Resources to the Development of Bexmarilimab CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.482 EUR
Average target price
11.6 EUR
Spread / Average Target
+682.79%
High Price Target
11.6 EUR
Spread / Highest target
+682.79%
Low Price Target
11.6 EUR
Spread / Lowest Target
+682.79%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. FARN Stock
  4. Consensus Faron Pharmaceuticals Oy